Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
December 31, 2023 -2.045M
September 30, 2023 -4.361M
June 30, 2023
March 31, 2023
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022 -8.166M
Date Value
December 31, 2021 -4.147M
September 30, 2021 -6.251M
June 30, 2021 -7.476M
March 31, 2021 -4.025M
December 31, 2020 -4.407M
September 30, 2020 -2.841M
June 30, 2020 -2.325M
March 31, 2020 -2.950M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc -25.16M
Cellectis SA -14.34M
Akari Therapeutics Plc -3.112M
DBV Technologies SA -52.52M
argenx SE --

Cash from Operations (Quarterly) Related Metrics